BRIEF published on 07/04/2025 at 07:05, 1 year 1 month ago Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote Euronext Actions Nasdaq Droit De Vote Innate Pharma
PRESS RELEASE published on 07/04/2025 at 07:00, 1 year 1 month ago Inside Information / Other news releases Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable) Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 1 year 1 month ago Innate Pharma participera à des conférences d'investisseurs clés Biotechnologie Immunothérapie Soins De Santé Conférences D'investisseurs Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 1 year 1 month ago Innate Pharma to Participate in Key Investor Conferences Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma
PRESS RELEASE published on 06/17/2025 at 07:00, 1 year 1 month ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
BRIEF published on 06/13/2025 at 07:05, 1 year 1 month ago L'IPH6501 d'Innate Pharma montre un potentiel dans le traitement du lymphome Innate Pharma Résultats Précliniques IPH6501 R-CHOP Lymphome
BRIEF published on 06/13/2025 at 07:05, 1 year 1 month ago Innate Pharma's IPH6501 Shows Potential in Lymphoma Treatment Innate Pharma Preclinical Results IPH6501 Lymphoma R-CHOP
PRESS RELEASE published on 06/13/2025 at 07:00, 1 year 1 month ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
BRIEF published on 05/13/2025 at 07:05, 1 year 2 months ago Innate Pharma Reports First Quarter 2025 Results Financial Results Clinical Trials Innate Pharma Sanofi Investment Lacutamab FDA
BRIEF published on 05/13/2025 at 07:05, 1 year 2 months ago Innate Pharma publie ses résultats du premier trimestre 2025 Résultats Financiers Essais Cliniques Innate Pharma Investissement Sanofi Lacutamab FDA
Published on 08/11/2026 at 07:00, 3 hours 43 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 10 hours 3 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 10 hours 18 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 11 hours 8 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 11 hours 13 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/11/2026 at 10:35, 8 minutes ago Lifefit launches and appoints Neymar Jr. as global brand ambassador
Published on 08/11/2026 at 10:05, 38 minutes ago The Ellinikon Sports Park Opens to All as Europe's Largest Urban Regeneration Project Accelerates Toward Completion
Published on 08/11/2026 at 10:00, 43 minutes ago Rising heat, growing exposure, changing hazards: benign first half of 2026 masks rising natural catastrophe risk, finds Swiss Re Institute
Published on 08/11/2026 at 09:20, 1 hour 23 minutes ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Published on 08/10/2026 at 18:00, 16 hours 43 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 16 hours 43 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 16 hours 58 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 22 hours 49 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
